Capricor Therapeutics logo
Capricor Therapeutics CAPR
€ 17.72 4.22%

Quartalsbericht 2024-Q3
hinzugefügt 14.11.2024

report update icon

Capricor Therapeutics Kennzahlen 2011-2024 | CAPR

Kennzahlen Jährlich Capricor Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-7.0 -3.7 -4.1 -7.5 -0.7 -1.0 18.0 -2.2 -3.3 -12.2 -15.5 -2.7 -4.1

P/S

6.2 42.5 336.6 330.2 5.7 9.2 16.4 10.1 7.7 15.9 273.4 25.9 14.6

EPS

-0.8 -1.2 -0.9 -0.9 -2.1 -5.2 0.1 -1.0 -0.8 -0.5 -0.8 -0.0 -0.1

EV (Enterprise Value)

177 M 137 M 57.5 M 76.2 M 6.09 M 15.7 M 42.7 M 60 M 54 M 87.9 M 142 M 5.29 M 19.3 M

EBITDA per Share

-0.86 -1.19 -0.9 -0.87 -2.04 -5.16 -5.48 -9.08 -7.86 -5.11 -6.55 -28.8 -65.5

EV/EBITDA

-2.1 -5.2 -0.2 -0.7 -3.0 -3.0 -3.7 -12.9 -20.3 -2.1 -3.8

PEG

0.32 0.21 0.13 0.1 -0.01 0.0 0.16 0.09 0.06 -0.32 -0.27 -0.04 -0.13

P/B

6.9 9.2 2.6 3.6 0.8 3.3 3.9 -10.1 -41.2 -12.2 -257.2 -30.3 23.8

P/CF

-6.1 22.1 -4.9 -9.7 -0.8 -1.1 -3.1 -2.5 -3.9 98.5 -22.0 -2.3 -4.3

ROE %

-98.61 -246.22 -63.83 -48.43 -111.73 -329.13 21.66 469.80 1246.14 99.49 1662.41 1131.43 -588.02

ROA %

-37.95 -57.93 -48.45 -39.45 -68.76 -164.28 14.94 -100.32 -80.01 -45.60 -160.56 -833.74 -355.99

ROCE %

-87.67 -112.03 -56.29 -43.26 -75.71 -191.78 -88.08 -122.55 -132.19 -82.07 -198.08 2347.89 -589.75

Current Ratio

1.6 1.3 4.1 11.3 11.7 6.7 9.4 3.7 2.1 1.8 1.8 0.5 2.4

DSO

- - - - 31.9 44.7 47.2 20.4 14.0 27.5 0.1 - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Betriebszyklus

- - - - - - - - - - - - -

Finanzkreislauf

- - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Capricor Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.38 -0.35 -0.31 - -0.25 -0.29 -0.31 - -0.26 -0.29 -0.32 - -0.17 -0.21 -0.23 - -0.2 -0.23 -0.3 - -0.43 -0.59 -0.75 - -1.35 -1.42 -0.14 - -0.12 -0.16 -0.17 - -0.29 -0.26 -0.26 - -0.18 -0.19 -0.23 - -0.13 -0.13 -0.1 - -0.15 -0.16 -0.14 - -0.01 -0.01 -0.02 - -0.03 -0.03 -0.03

EBITDA per Share

-0.38 -0.35 -0.32 - -0.26 -0.3 -0.32 - -0.26 -0.3 -0.32 - -0.18 -0.22 -0.23 - -0.19 -0.23 -0.3 - -0.4 -0.57 -0.75 - -1.33 -1.41 -0.14 - -0.11 -0.15 -0.16 - -0.28 -0.25 -0.25 - -0.17 -0.19 -0.23 - -0.12 -0.13 -0.1 - -0.14 -0.15 -0.14 - -0.01 -0.02 -0.02 - -0.03 -0.02 -0.03

ROE %

190.33 566.21 392.12 -37.41 -78.71 -477.49 -245.73 -110.99 -121.69 -91.09 -67.36 -39.09 -52.95 -56.12 -54.25 -33.61 -57.10 -66.73 -84.30 -90.25 -179.86 -245.98 -305.40 -258.50 -282.86 -217.61 -159.20 -87.95 45.28 202.87 350.93 356.93 639.16 788.16 973.72 921.83 946.54 689.02 410.87 68.63 357.52 621.71 900.89 2255.03 3386.46 4229.01 5056.71 3394.30 2806.29 1086.84 -632.61 -1764.05 -588.02 -588.02 -588.02

ROA %

-79.26 -82.95 -70.22 -47.63 -59.45 -54.06 -50.29 -36.10 -45.22 -42.53 -42.18 -32.85 -44.14 -46.31 -44.49 -27.38 -41.84 -45.00 -53.35 -55.54 -100.27 -130.54 -156.72 -129.03 -145.83 -117.91 -94.65 -60.67 -89.12 -100.76 -104.44 -76.22 -94.34 -84.01 -78.43 -59.19 -70.51 -63.72 -55.54 -31.46 -59.36 -75.94 -94.02 -217.80 -1051.54 -1857.38 -2661.78 -2501.22 -2857.21 -2379.46 -1901.71 -1067.97 -355.99 -355.99 -355.99

ROCE %

-297.71 -442.21 -440.77 -282.72 -303.80 -162.43 -110.08 -55.56 -66.32 -56.00 -50.82 -37.56 -49.92 -51.53 -48.73 -30.05 -45.98 -49.55 -58.75 -61.19 -113.39 -149.66 -181.53 -150.42 -168.48 -134.34 -105.39 -65.62 -103.44 -123.21 -133.37 -101.52 -131.40 -123.45 -122.24 -97.76 -118.01 -108.39 -96.49 -56.61 -99.48 -122.10 -148.25 178.56 523.01 910.34 1419.54 1267.45 1128.25 644.60 75.78 -389.32 -139.20 -105.96 -144.16

Current Ratio

3.8 1.4 1.6 1.6 0.9 1.1 1.1 1.3 1.4 1.5 1.6 4.2 6.8 6.1 6.1 5.4 5.4 5.4 5.4 2.6 2.6 2.6 2.6 2.0 2.0 2.0 2.0 3.2 3.2 3.2 3.2 0.8 0.8 0.8 0.8 0.9 0.9 0.9 0.9 0.7 0.7 0.7 0.7 0.9 0.9 0.9 0.9 10.2 0.6 0.6 0.6 2.5 2.5 2.5 -

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Finanzkreislauf

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung